A new systematic review guided by the CanTest Framework found that while there is a large number of biomarkers being developed for the detection of upper GI cancers, more evidence from evaluations in low-prevalence populations like primary care is still needed before their adoption in clinical practice can be recommended. Cancers of the stomach, oesophagus, […]